ULS UL Solutions Inc. NYSE · United States

UL Solutions (ULS) news

UL Solutions Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker ULS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest UL Solutions news

We have not published a story on UL Solutions yet. When there is news, it will appear here.

UL Solutions annual financials

Line	FY2025	FY2024
Revenue	$3.05 billion	$2.87 billion
Net income (loss)	$325.0 million	$326.0 million
Cash from operations	$600.0 million	$524.0 million
Cash and equivalents	$295.0 million	$298.0 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $434.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about UL Solutions

What is the ticker symbol of UL Solutions?

UL Solutions Inc. trades under the ticker ULS on NYSE.

Where is UL Solutions listed?

UL Solutions Inc. is listed on NYSE.

Which country or territory is UL Solutions listed under?

Our directory records UL Solutions Inc. under United States.

Does aibio.space cover UL Solutions?

aibio.space lists UL Solutions Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was UL Solutions's revenue last year?

$3.05 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is UL Solutions profitable?

UL Solutions Inc. reported net income of $325.0 million for the fiscal year ended Dec 31, 2025, and generated $600.0 million of cash from operations, per its annual report to the SEC.

How much cash does UL Solutions have?

$434.0 million in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: UL Solutions

Members talk about UL Solutions (ULS). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at UL Solutions, newest first. Each line links the filing it comes from.

Aug 4, 2026Distress
Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.02,7.01,9.01). Source
May 5, 2026Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:ULS on TradingView.

Listing details

Company: UL Solutions Inc.
Ticker: ULS
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction